Cancer Market Research Reports & Industry Analysis

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Japanese cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Spanish cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the UK cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the US cancer ...

The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors of Anaplastic Lymphoma Kinase (ALK) for the treatment of solid tumors as of August 2013. Purchase ...

The present Competitive Intelligence report about Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors provides a competitor evaluation in the field of small molecule ... that repair DNA damage. Despite the recent failure of Sanofi’s PARP inhibitor iniparib, presentation of results from clinical studies with other ...

... when purchasing Hard Copy License depending on the location. “Ovarian Cancer Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... reader to identify and understand the therapeutics associated with the Ovarian Cancer disease. The information for particular drug in development process ...

... purchasing Hard Copy License depending on the location. “Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... . Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, ...

... and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: France, Germany, Italy ...

... in the pipeline. According to RNCOS' report, "Cancer Monoclonal Antibodies Market Forecast to 2017", the market for cancer mAbs is estimated at US$ 24 Billion, and ... approval of these drugs will drive a major change in the market in terms of market share of current drugs. Finally, RNCOS concludes its report ...

... contains 450 tables from Venture Planning Group’s new 7-country study, “Tumor Markers: US, Europe, Japan,” including supplier shares, as well as test volume ... Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker and country. Five-year ...

... development and marketing strategies. Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker. Five-year test volume and sales forecasts for major tumor markers by market segment, including: Hospitals Commercial/Private Laboratories Physician Offices ...

... 320 tables from Venture Planning Group’s new 5-country study, “Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares,” including supplier ... Germany Italy Spain UK Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker and country. Five-year ...

... growth. According to our latest research report “Cancer Generics Market Outlook 2017”, this market for cancer generics is expected to grow at 13%, reaching US$ 19 Billion ... oral and injectable options, encompassing all the recently approved generics along with existing ones. The detailed study of each drug ...

... new 7-country study, “Competing in the Global Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for 40 ... Coverage France Germany Italy Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker ...

... Venture Planning Group new report, “Competing in the US Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for ... strategies. Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker. Five-year test volume and sales ...

... Group new 5-country study, “Competing in the European Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for ... Spain UK Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker and country. Five-year test volume and ...

... potential market entrants identify and evaluate emerging opportunities in the European coagulation test market during the next five years, and assist ... Germany Italy Spain UK Sales and Market Share Analysis Sales and market shares of major coagulation testing instrument and reagent suppliers. Market ...

... potential market entrants identify and evaluate emerging opportunities in the global coagulation test market during the next five years, and assist industry ... Japan Spain UK USA Sales and Market Share Analysis Sales and market shares of major coagulation testing instrument and reagent suppliers. Market ...

... ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells ... over. The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions ...

... and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, ... diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...

... Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

... Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

... Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

... Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

... Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

... shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...

... shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...

... report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key ... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed ...

... report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key ... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed ...

This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

... report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key ... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed ...

This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

... Hemoglobin HCG 25-Hydroxy Vitamin D2 and D3 Occult Blood PAP PSA Thyroglobulin Vitamin B-12 During the next decade, the tumor markers and ... as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, ...

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and ...

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and ...

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $2,450. Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and ...

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and ...

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...